The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Safety and clinical activity of durvalumab monotherapy in patients with microsatellite instability–high (MSI-H) tumors.
 
Neil Howard Segal
Consulting or Advisory Role - Aduro Biotech; AstraZeneca/MedImmune; Boehringer Ingelheim; Bristol-Myers Squibb; Chugai Pharma; EMD Serono; Gritstone Bio; Horizon Pharma; IFM Therapeutics; Imugene; Kyn therapeutics; Merck; Pfizer; Pieris Pharmaceuticals; PureTech; Roche/Genentech; Synlogic; TRM Oncology
Research Funding - Bristol-Myers Squibb; Incyte; MedImmune; Merck; Pfizer; Roche/Genentech
 
Zev A. Wainberg
Consulting or Advisory Role - Aduro Biotech; Array BioPharma; Bristol-Myers Squibb; Five Prime Therapeutics; Genentech; Lilly; Merck; Merck KGaA; Novartis; Sirtex Medical
Research Funding - Five Prime Therapeutics (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Plexxikon (Inst)
Travel, Accommodations, Expenses - Genentech
 
Michael J. Overman
Consulting or Advisory Role - Bristol-Myers Squibb; Gritstone Bio; MedImmune; Roche/Genentech
Research Funding - Bristol-Myers Squibb; MedImmune; Merck; Roche
 
Paolo Antonio Ascierto
Consulting or Advisory Role - Amgen; Array BioPharma; AstraZeneca; Bristol-Myers Squibb; Genmab; Idera; Incyte; MedImmune; Merck Serono; Merck Sharp & Dohme; Newlink Genetics; Novartis; Pierre Fabre; Roche/Genentech; Sanofi; Sun Pharma; Syndax; Ultimovacs
Research Funding - Array BioPharma (Inst); Bristol-Myers Squibb (Inst); Roche/Genentech (Inst)
 
Hendrik-Tobias Arkenau
No Relationships to Disclose
 
Marcus O. Butler
Honoraria - Bristol-Myers Squibb; Merck; Novartis; Roche
Consulting or Advisory Role - Adaptimmune; Bristol-Myers Squibb; EMD Serono; GlaxoSmithKline; Immunocore; Immunovaccine; Merck; Novartis
Research Funding - Merck
Expert Testimony - Merck
 
Joseph Paul Eder
Research Funding - AstraZeneca (Inst)
 
Ulrich Keilholz
Honoraria - AstraZeneca; Bristol-Myers Squibb; Glycotope GmbH; Merck KGaA; MSD Oncology; Novartis; Pfizer; Roche/Genentech
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Merck Serono; MSD Oncology; pfizer
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb; Glycotope GmbH; Merck Serono; MSD Oncology; Novartis
Research Funding - AstraZeneca/MedImmune (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Ipsen; Merck Serono; MSD Oncology
 
Dong-Wan Kim
No Relationships to Disclose
 
David Cunningham
Research Funding - 4SC (Inst); Amgen (Inst); AstraZeneca (Inst); Bayer (Inst); Celgene (Inst); Clovis Oncology (Inst); Janssen (Inst); Lilly (Inst); MedImmune (Inst); Merck (Inst); Merrimack (Inst); Sanofi (Inst)
 
Samir N. Khleif
Leadership - Advaxis
Stock and Other Ownership Interests - Advaxis
Honoraria - Cancer Panels; Northwest Biotherapeutics; Syndax
Consulting or Advisory Role - Abdali Hospital; Alanus LLC; AratingaBio Inc; AstraZeneca/MedImmune; BiolineRx; CanImGuide Therapeutics; Clinical Information Technologies LLC; CytomX Therapeutics; GeorgiaImmune LLC; Gilead Sciences; Hikma Pharmaceuticals; IO Biotech; KHAR Medical; Nektar; Newlink Genetics; PDS; Tessa Therapeutics
Research Funding - AstraZeneca (Inst); BiolineRx (Inst); IO Biotech (Inst); Lycera (Inst); MedImmune (Inst); Sanofi (Inst); Syndax (Inst)
 
Ludovic Doucet
No Relationships to Disclose
 
Jong-Seok Lee
No Relationships to Disclose
 
John J. Nemunaitis
Employment - Gradalis
Leadership - Gradalis
Stock and Other Ownership Interests - Gradalis
Honoraria - Amgen; AstraZeneca
Consulting or Advisory Role - Amgen; AstraZeneca
Speakers' Bureau - Amgen; AstraZeneca
Patents, Royalties, Other Intellectual Property - Gradalis
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Baxalta; Takeda
 
Ulka N. Vaishampayan
Honoraria - Bayer; Bristol-Myers Squibb; Exelixis; Genentech; Janssen; Novartis; Pfizer; Sanofi
Consulting or Advisory Role - Astellas Pharma; Bayer; Bristol-Myers Squibb; Exelixis; Genentech/Roche; Pfizer
Speakers' Bureau - Bayer; Bristol-Myers Squibb; Exelixis; Genentech/Roche; Pfizer; Sanofi
Research Funding - Astellas Pharma; Bristol-Myers Squibb; Exelixis; Novartis; Pfizer
 
Jared Weiss
Stock and Other Ownership Interests - Nektar
Honoraria - Pfizer
Consulting or Advisory Role - AstraZeneca; BioMarck Pharmaceuticals; Celgene; EMD Serono; Genentech; Inivata
Research Funding - Astellas Pharma (Inst); AstraZeneca/MedImmune (Inst); Celgene (Inst); Merck (Inst); novartis (Inst); Pfizer (Inst)
 
Chen Gao
Employment - MedImmune
Stock and Other Ownership Interests - MedImmune
 
Shaad Essa Abdullah
Employment - MedImmune
Stock and Other Ownership Interests - MedImmune
 
Antoine Hollebecque
Honoraria - Merck Serono
Consulting or Advisory Role - Amgen
Travel, Accommodations, Expenses - Amgen; SERVIER